Our findings suggest that when used in combination with DPP-4i′s, bumetanide, captopril, acetaminophen, cotrimoxazole, and pantoprazole may increase the risk of hypoglycemia more than twice and require the intervention of glucose infusion or glucagon injection. Here, GCG is linked to Hypoglycemia.